Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.52
SHTDF's Cash to Debt is ranked lower than
70% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.71 vs. SHTDF: 0.52 )
Ranked among companies with meaningful Cash to Debt only.
SHTDF' s 10-Year Cash to Debt Range
Min: 0.39  Med: 0.95 Max: 4.4
Current: 0.52
0.39
4.4
Equity to Asset 0.21
SHTDF's Equity to Asset is ranked lower than
83% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.43 vs. SHTDF: 0.21 )
Ranked among companies with meaningful Equity to Asset only.
SHTDF' s 10-Year Equity to Asset Range
Min: 0.12  Med: 0.21 Max: 0.36
Current: 0.21
0.12
0.36
Interest Coverage 3.59
SHTDF's Interest Coverage is ranked lower than
81% of the 27 Companies
in the Global Medical Distribution industry.

( Industry Median: 79.78 vs. SHTDF: 3.59 )
Ranked among companies with meaningful Interest Coverage only.
SHTDF' s 10-Year Interest Coverage Range
Min: 3.43  Med: 4.41 Max: 7.37
Current: 3.59
3.43
7.37
F-Score: 6
Z-Score: 2.39
M-Score: -2.29
WACC vs ROIC
4.35%
14.92%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 3.93
SHTDF's Operating margin (%) is ranked lower than
51% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.95 vs. SHTDF: 3.93 )
Ranked among companies with meaningful Operating margin (%) only.
SHTDF' s 10-Year Operating margin (%) Range
Min: 2.02  Med: 3.56 Max: 3.93
Current: 3.93
2.02
3.93
Net-margin (%) 2.27
SHTDF's Net-margin (%) is ranked lower than
56% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.84 vs. SHTDF: 2.27 )
Ranked among companies with meaningful Net-margin (%) only.
SHTDF' s 10-Year Net-margin (%) Range
Min: 0.77  Med: 2.26 Max: 2.74
Current: 2.27
0.77
2.74
ROE (%) 12.04
SHTDF's ROE (%) is ranked higher than
57% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.65 vs. SHTDF: 12.04 )
Ranked among companies with meaningful ROE (%) only.
SHTDF' s 10-Year ROE (%) Range
Min: 10.39  Med: 11.88 Max: 32.08
Current: 12.04
10.39
32.08
ROA (%) 3.90
SHTDF's ROA (%) is ranked lower than
54% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.31 vs. SHTDF: 3.90 )
Ranked among companies with meaningful ROA (%) only.
SHTDF' s 10-Year ROA (%) Range
Min: 3.86  Med: 4.36 Max: 5.93
Current: 3.9
3.86
5.93
ROC (Joel Greenblatt) (%) 20.27
SHTDF's ROC (Joel Greenblatt) (%) is ranked lower than
54% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 21.16 vs. SHTDF: 20.27 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
SHTDF' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 20.22  Med: 34.51 Max: 80.69
Current: 20.27
20.22
80.69
Revenue Growth (3Y)(%) 22.40
SHTDF's Revenue Growth (3Y)(%) is ranked higher than
87% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.80 vs. SHTDF: 22.40 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
SHTDF' s 10-Year Revenue Growth (3Y)(%) Range
Min: 21.3  Med: 27.50 Max: 33.3
Current: 22.4
21.3
33.3
EBITDA Growth (3Y)(%) 23.10
SHTDF's EBITDA Growth (3Y)(%) is ranked higher than
80% of the 30 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.40 vs. SHTDF: 23.10 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
SHTDF' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 23.1  Med: 29.70 Max: 58.7
Current: 23.1
23.1
58.7
EPS Growth (3Y)(%) 19.90
SHTDF's EPS Growth (3Y)(%) is ranked higher than
76% of the 29 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.50 vs. SHTDF: 19.90 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
SHTDF' s 10-Year EPS Growth (3Y)(%) Range
Min: 19.2  Med: 21.85 Max: 76.7
Current: 19.9
19.2
76.7
» SHTDF's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with SHTDF

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 22.10
SHTDF's P/E(ttm) is ranked higher than
57% of the 30 Companies
in the Global Medical Distribution industry.

( Industry Median: 24.90 vs. SHTDF: 22.10 )
Ranked among companies with meaningful P/E(ttm) only.
SHTDF' s 10-Year P/E(ttm) Range
Min: 17.4  Med: 24.70 Max: 46.68
Current: 22.1
17.4
46.68
PE(NRI) 22.10
SHTDF's PE(NRI) is ranked higher than
57% of the 30 Companies
in the Global Medical Distribution industry.

( Industry Median: 24.90 vs. SHTDF: 22.10 )
Ranked among companies with meaningful PE(NRI) only.
SHTDF' s 10-Year PE(NRI) Range
Min: 17.4  Med: 24.70 Max: 46.68
Current: 22.1
17.4
46.68
P/B 2.48
SHTDF's P/B is ranked higher than
50% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.40 vs. SHTDF: 2.48 )
Ranked among companies with meaningful P/B only.
SHTDF' s 10-Year P/B Range
Min: 1.82  Med: 2.77 Max: 4.77
Current: 2.48
1.82
4.77
P/S 0.32
SHTDF's P/S is ranked higher than
74% of the 42 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.07 vs. SHTDF: 0.32 )
Ranked among companies with meaningful P/S only.
SHTDF' s 10-Year P/S Range
Min: 0.23  Med: 0.35 Max: 0.81
Current: 0.32
0.23
0.81
PFCF 17.26
SHTDF's PFCF is ranked higher than
70% of the 23 Companies
in the Global Medical Distribution industry.

( Industry Median: 19.21 vs. SHTDF: 17.26 )
Ranked among companies with meaningful PFCF only.
SHTDF' s 10-Year PFCF Range
Min: 10.63  Med: 16.94 Max: 21.39
Current: 17.26
10.63
21.39
POCF 11.34
SHTDF's POCF is ranked higher than
84% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 15.31 vs. SHTDF: 11.34 )
Ranked among companies with meaningful POCF only.
SHTDF' s 10-Year POCF Range
Min: 7.97  Med: 12.49 Max: 46.5
Current: 11.34
7.97
46.5
EV-to-EBIT 11.21
SHTDF's EV-to-EBIT is ranked higher than
73% of the 30 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.64 vs. SHTDF: 11.21 )
Ranked among companies with meaningful EV-to-EBIT only.
SHTDF' s 10-Year EV-to-EBIT Range
Min: 9.3  Med: 13.50 Max: 22.8
Current: 11.21
9.3
22.8
PEG 0.87
SHTDF's PEG is ranked higher than
85% of the 20 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.68 vs. SHTDF: 0.87 )
Ranked among companies with meaningful PEG only.
SHTDF' s 10-Year PEG Range
Min: 0.61  Med: 0.78 Max: 1.05
Current: 0.87
0.61
1.05
Shiller P/E 32.29
SHTDF's Shiller P/E is ranked higher than
56% of the 25 Companies
in the Global Medical Distribution industry.

( Industry Median: 31.67 vs. SHTDF: 32.29 )
Ranked among companies with meaningful Shiller P/E only.
SHTDF' s 10-Year Shiller P/E Range
Min: 25.5  Med: 34.50 Max: 41.38
Current: 32.29
25.5
41.38
Current Ratio 1.28
SHTDF's Current Ratio is ranked lower than
75% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.64 vs. SHTDF: 1.28 )
Ranked among companies with meaningful Current Ratio only.
SHTDF' s 10-Year Current Ratio Range
Min: 1.09  Med: 1.28 Max: 1.67
Current: 1.28
1.09
1.67
Quick Ratio 1.05
SHTDF's Quick Ratio is ranked lower than
63% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.26 vs. SHTDF: 1.05 )
Ranked among companies with meaningful Quick Ratio only.
SHTDF' s 10-Year Quick Ratio Range
Min: 0.85  Med: 1.04 Max: 1.37
Current: 1.05
0.85
1.37
Days Inventory 36.12
SHTDF's Days Inventory is ranked higher than
60% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 49.37 vs. SHTDF: 36.12 )
Ranked among companies with meaningful Days Inventory only.
SHTDF' s 10-Year Days Inventory Range
Min: 29.1  Med: 36.28 Max: 37.72
Current: 36.12
29.1
37.72
Days Sales Outstanding 114.36
SHTDF's Days Sales Outstanding is ranked lower than
89% of the 37 Companies
in the Global Medical Distribution industry.

( Industry Median: 55.91 vs. SHTDF: 114.36 )
Ranked among companies with meaningful Days Sales Outstanding only.
SHTDF' s 10-Year Days Sales Outstanding Range
Min: 75.63  Med: 94.64 Max: 113.99
Current: 114.36
75.63
113.99

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.26
SHTDF's Dividend Yield is ranked lower than
63% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.63 vs. SHTDF: 1.26 )
Ranked among companies with meaningful Dividend Yield only.
SHTDF' s 10-Year Dividend Yield Range
Min: 0.85  Med: 1.12 Max: 1.61
Current: 1.26
0.85
1.61
Dividend Payout 0.23
SHTDF's Dividend Payout is ranked higher than
72% of the 29 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.35 vs. SHTDF: 0.23 )
Ranked among companies with meaningful Dividend Payout only.
SHTDF' s 10-Year Dividend Payout Range
Min: 0.23  Med: 0.24 Max: 0.28
Current: 0.23
0.23
0.28
Dividend growth (3y) 18.60
SHTDF's Dividend growth (3y) is ranked higher than
61% of the 18 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.00 vs. SHTDF: 18.60 )
Ranked among companies with meaningful Dividend growth (3y) only.
SHTDF' s 10-Year Dividend growth (3y) Range
Min: 0  Med: 0.00 Max: 18.6
Current: 18.6
0
18.6
Yield on cost (5-Year) 1.26
SHTDF's Yield on cost (5-Year) is ranked lower than
72% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.99 vs. SHTDF: 1.26 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
SHTDF' s 10-Year Yield on cost (5-Year) Range
Min: 0.85  Med: 1.12 Max: 1.61
Current: 1.26
0.85
1.61
Share Buyback Rate -3.10
SHTDF's Share Buyback Rate is ranked lower than
67% of the 30 Companies
in the Global Medical Distribution industry.

( Industry Median: -0.60 vs. SHTDF: -3.10 )
Ranked among companies with meaningful Share Buyback Rate only.
SHTDF' s 10-Year Share Buyback Rate Range
Min: -3.1  Med: -6.80 Max: -12.9
Current: -3.1

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 7.49
SHTDF's Price/Net Current Asset Value is ranked lower than
57% of the 23 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.64 vs. SHTDF: 7.49 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
SHTDF' s 10-Year Price/Net Current Asset Value Range
Min: 6.58  Med: 9.55 Max: 13.68
Current: 7.49
6.58
13.68
Price/Tangible Book 3.48
SHTDF's Price/Tangible Book is ranked lower than
53% of the 36 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.00 vs. SHTDF: 3.48 )
Ranked among companies with meaningful Price/Tangible Book only.
SHTDF' s 10-Year Price/Tangible Book Range
Min: 2.99  Med: 3.72 Max: 5.59
Current: 3.48
2.99
5.59
Price/Projected FCF 1.37
SHTDF's Price/Projected FCF is ranked higher than
65% of the 20 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.42 vs. SHTDF: 1.37 )
Ranked among companies with meaningful Price/Projected FCF only.
SHTDF' s 10-Year Price/Projected FCF Range
Min: 1.21  Med: 1.33 Max: 2.23
Current: 1.37
1.21
2.23
Price/Median PS Value 0.91
SHTDF's Price/Median PS Value is ranked higher than
80% of the 35 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.23 vs. SHTDF: 0.91 )
Ranked among companies with meaningful Price/Median PS Value only.
SHTDF' s 10-Year Price/Median PS Value Range
Min: 0.73  Med: 0.87 Max: 2.12
Current: 0.91
0.73
2.12
Price/Peter Lynch Fair Value 0.89
SHTDF's Price/Peter Lynch Fair Value is ranked higher than
83% of the 12 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.58 vs. SHTDF: 0.89 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
SHTDF' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.78  Med: 0.87 Max: 1.77
Current: 0.89
0.78
1.77
Price/Graham Number 1.52
SHTDF's Price/Graham Number is ranked higher than
58% of the 26 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.70 vs. SHTDF: 1.52 )
Ranked among companies with meaningful Price/Graham Number only.
SHTDF' s 10-Year Price/Graham Number Range
Min: 1.29  Med: 1.53 Max: 2.32
Current: 1.52
1.29
2.32
Earnings Yield (Greenblatt) (%) 8.90
SHTDF's Earnings Yield (Greenblatt) (%) is ranked higher than
80% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.10 vs. SHTDF: 8.90 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
SHTDF' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 4.4  Med: 7.40 Max: 10.7
Current: 8.9
4.4
10.7
Forward Rate of Return (Yacktman) (%) 31.25
SHTDF's Forward Rate of Return (Yacktman) (%) is ranked higher than
85% of the 26 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.31 vs. SHTDF: 31.25 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
SHTDF' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: 29.5  Med: 31.70 Max: 45.7
Current: 31.25
29.5
45.7

Business Description

Industry: Medical Distribution » Medical Distribution
Compare: » details
Traded in other countries:01099.Hongkong, X2S.Germany,
Sinopharm Group Co Ltd was incorporated in the People's Republic of China on January 8, 2003. The Company and its subsidiaries is mainly engaged in distribution of medicines, medical device and pharmaceutical products to hospitals, other distributors, retail drug stores and clinics, operation of pharmaceutical chain stores, and distribution of laboratory supplies, manufacture and distribution of chemical reagents, production and sale of pharmaceutical products. The Company's operations are divided into three segments Pharmaceuticals distribution segment, Retail pharmacy segment and Other business segment. Pharmaceutical distribution is the Group's principal business. The Group provides distribution, logistics and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, customers and other suppliers. The Group has established a network of retail drug stores in cities of China via direct operations and franchises. The Group is also engaged in the production and sale of pharmaceutical products, chemical reagents and laboratory supplies.
» More Articles for OTCPK:SHTDF

Headlines

Articles On GuruFocus.com
Matthews China Fund Comments on Sinopharm Group Oct 20 2014 
Matthews China Fund Q3 2014 Commentary Oct 17 2014 
The Matthews China Fund's Top Five Fourth Quarter Holdings Feb 04 2014 

More From Other Websites
No related articles found.

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK